M
Michael A. Heneghan
Researcher at University of Cambridge
Publications - 289
Citations - 10869
Michael A. Heneghan is an academic researcher from University of Cambridge. The author has contributed to research in topics: Liver transplantation & Autoimmune hepatitis. The author has an hindex of 51, co-authored 245 publications receiving 9041 citations. Previous affiliations of Michael A. Heneghan include National Health Service & King's College.
Papers
More filters
Journal ArticleDOI
The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?
M Al-Freah,Stephen Kriese,Matthew R. Foxton,Alberto Quaglia,Adrian Bomford,Nigel Heaton,John O'Grady,Kosh Agarwal,Julia Wendon,Michael A. Heneghan +9 more
TL;DR: A limited role is found for SF as a prognostic indicator for pre‐ or post‐transplant survival in patients assessed for first LT, 2000–2007.
Journal ArticleDOI
Con: Steroids Should Not Be Withdrawn in Transplant Recipients With Autoimmune Hepatitis.
TL;DR: The treatment for AIH recurrence includes reintroduction or increase in the dose of steroids with or without the addition of azathioprine, and identifying patients who are at the greatest risk for disease recurrence and who would benefit from intensified IS might be an option.
Journal ArticleDOI
LBO-02-Elafibranor, a peroxisome proliferator-activted receptor alpha and delta agonist demonstrates favourable efficacy and safety in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid treatment
PD Dr. Schattenberg Jörn,Albert Parés,Kris V. Kowdley,Michael A. Heneghan,Stephen H. Caldwell,Daniel Pratt,Alan Bonder,Gideon M. Hirschfield,MB Bchir,Cynthia Levy,John M. Vierling,David Jones,S. Megnien,Rémy Hanf,David Magrez,Pascal Birman,Velimir A. Luketic +16 more
Journal ArticleDOI
Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients.
Mussarat N. Rahim,Eleni Theocharidou,Katherine Gar Yen Lau,Refah Ahmed,Flevin Marattukalam,Lisa Long,Mary Cannon,Michael A. Heneghan +7 more
TL;DR: In this article, the authors report the largest experience of IVF in women with liver-related subfertility (LRSF) who had undergone 57 IVF cycles between 1990 and 2019.
Journal ArticleDOI
A novel microRNA-based prognostic model outperforms standard prognostic models in patients with acetaminophen-induced acute liver failure.
Oliver D Tavabie,Constantine J. Karvellas,Siamak Salehi,Jaime L. Speiser,Christopher F. Rose,Krishna Menon,Andreas Prachalias,Michael A. Heneghan,Kosh Agarwal,William M. Lee,Mark J. W. McPhail,Varuna Aluvihare,W.M. Lee,Anne M. Larson,Iris Liou,Oren K. Fix,Michael L. Schilsky,Timothy M. McCashland,J. Eileen Hay,Natalie Murray,A. Obaid S. Shaikh,Andres T. Blei,Daniel Ganger,Atif Zaman,Steven Han,Robert J. Fontana,Brendan M. McGuire,Raymond T. Chung,Alastair D. Smith,Robert S. Brown,Jeffrey S. Crippin,Edwin Harrison,Adrian Reuben,Santiago J. Munoz,Rajender Reddy,R. Todd Stravitz,Lorenzo Rossaro,Raj Satyanarayana,Tarek Hassanein,Jodi Olson,Ram Subramanian,James Hanje,Bilal Hameed,Ezmina Lalani,Carla Pezzia,Corron Sanders,Nahid Attar,Linda S. Hynan,Valerie Durkalski,Wenle Zhao,Jaime Speiser,Catherine Dillon,Holly Battenhouse,Michelle Gottfried +53 more
TL;DR: In this article, a microRNA signature associated with successful regeneration post-auxiliary liver transplant and with recovery from acute liver failure was used to develop outcome prediction models for APAP-ALF.